Quanjun Yang

2.0k total citations · 1 hit paper
76 papers, 1.5k citations indexed

About

Quanjun Yang is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Quanjun Yang has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Oncology and 19 papers in Physiology. Recurrent topics in Quanjun Yang's work include Nutrition and Health in Aging (14 papers), Muscle Physiology and Disorders (12 papers) and CAR-T cell therapy research (7 papers). Quanjun Yang is often cited by papers focused on Nutrition and Health in Aging (14 papers), Muscle Physiology and Disorders (12 papers) and CAR-T cell therapy research (7 papers). Quanjun Yang collaborates with scholars based in China, United States and France. Quanjun Yang's co-authors include Cheng Guo, Lili Wan, Yonglong Han, Xipeng Sun, Jinlu Huang, Linlin Chen, Yan Huo, Hong Zhang, Jinmiao Lu and Lupeng Ye and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Cell Metabolism.

In The Last Decade

Quanjun Yang

71 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy

2022 143 citations Lupeng Ye, Jonathan J. Park et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Quanjun Yang China	22	805	378	262	198	166	76	1.5k
Jing Ma China	23	656 0.8×	233 0.6×	169 0.6×	147 0.7×	201 1.2×	73	1.4k
Masoud Darabi Iran	24	617 0.8×	199 0.5×	199 0.8×	177 0.9×	284 1.7×	108	1.8k
Shuhui Zhang China	22	761 0.9×	323 0.9×	121 0.5×	131 0.7×	240 1.4×	65	1.5k
Domenico D’Arca Italy	16	838 1.0×	303 0.8×	246 0.9×	166 0.8×	168 1.0×	38	1.6k
Tingting Fang China	26	825 1.0×	191 0.5×	201 0.8×	176 0.9×	312 1.9×	82	1.6k
Luqiao Wang China	16	858 1.1×	169 0.4×	138 0.5×	312 1.6×	261 1.6×	45	1.6k
Ju Chen China	16	940 1.2×	381 1.0×	107 0.4×	297 1.5×	198 1.2×	64	1.7k
Hua Fan Germany	20	610 0.8×	475 1.3×	184 0.7×	309 1.6×	121 0.7×	46	1.8k
Caiping Chen China	21	782 1.0×	214 0.6×	127 0.5×	161 0.8×	215 1.3×	68	1.5k

Countries citing papers authored by Quanjun Yang

Since Specialization

Citations

This map shows the geographic impact of Quanjun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanjun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanjun Yang more than expected).

Fields of papers citing papers by Quanjun Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quanjun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanjun Yang. The network helps show where Quanjun Yang may publish in the future.

Co-authorship network of co-authors of Quanjun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Quanjun Yang. A scholar is included among the top collaborators of Quanjun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quanjun Yang. Quanjun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Yue, et al.. (2025). Coumarins in the tumor-immune application: from molecular mechanisms to therapeutic innovations. Frontiers in Immunology. 16. 1681892–1681892.

Bai, Dong-Hoon, et al.. (2025). Arginine Metabolism in Cancer Biology and Immunotherapy. Immune Network. 25(4). e30–e30. 2 indexed citations

Yang, Quanjun, Xiaohong Xu, Xia Wu, et al.. (2024). Outcome differences of starting Paxlovid for COVID-19 within or after five days of symptoms onset in the elderly: a retrospective study. The Journal of Infection in Developing Countries. 18(9). 1373–1379.

Yang, Quanjun, Xinting Zhu, Ping Huang, et al.. (2024). BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism. Molecular Therapy. 32(9). 3128–3144. 11 indexed citations

Xiang, Danfeng, Quanjun Yang, Lingyan Xu, et al.. (2024). Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma. BMC Complementary Medicine and Therapies. 24(1). 67–67. 3 indexed citations

Renauer, Paul, Jonathan J. Park, Meizhu Bai, et al.. (2023). Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function. Cancer Immunology Research. 11(8). 1068–1084. 19 indexed citations

Yang, Quanjun, et al.. (2023). Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2290458–2290458. 4 indexed citations

Hao, Juan, Yi Xu, Kan Lu, et al.. (2023). Gentiopicroside Ameliorated Ductular Reaction and Inflammatory Response inDDC-induced Murine Cholangiopathies Model. Current Molecular Pharmacology. 17. e18761429251911–e18761429251911. 4 indexed citations

Yang, Quanjun, Juan Hao, Yaxian Wang, et al.. (2022). D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment. Molecular Therapy. 30(3). 1188–1200. 36 indexed citations

10.

Ye, Lupeng, Jonathan J. Park, Lei Peng, et al.. (2022). A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metabolism. 34(4). 595–614.e14. 143 indexed citations breakdown →

11.

Zhang, Hong, Linlin Chen, Xipeng Sun, et al.. (2021). Daidzein alleviates cisplatin‐induced muscle atrophy by regulating Glut4/AMPK/FoxO pathway. Phytotherapy Research. 35(8). 4363–4376. 38 indexed citations

12.

Zheng, Shuier, Fenglin Wang, Jin Huang, et al.. (2021). Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden. Frontiers in Endocrinology. 12. 625226–625226. 5 indexed citations

13.

Zhang, Hong, Linlin Chen, Xipeng Sun, et al.. (2020). Matrine: A Promising Natural Product With Various Pharmacological Activities. Frontiers in Pharmacology. 11. 588–588. 121 indexed citations

14.

Ye, Lupeng, Jonathan J. Park, Matthew B. Dong, et al.. (2019). In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma. Nature Biotechnology. 37(11). 1302–1313. 148 indexed citations

15.

Zhou, Zhiyong, Lili Wan, Quanjun Yang, et al.. (2016). Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model. Toxicology Letters. 259. 124–132. 31 indexed citations

16.

Li, Jie, Yan Huo, Jin Lü, et al.. (2016). Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats. Scientific Reports. 6(1). 33593–33593. 22 indexed citations

17.

Yang, Quanjun, Genjin Yang, Bin Li, et al.. (2013). Serum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice. Molecular BioSystems. 9(12). 3015–3025. 19 indexed citations

18.

Yang, Quanjun, Zhiyong Zhou, Yan Li, et al.. (2013). Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma. Phytomedicine. 20(11). 992–998. 19 indexed citations

19.

Zhou, Zhiyong, Lili Wan, Quanjun Yang, et al.. (2013). Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib. Toxicology and Applied Pharmacology. 272(1). 238–244. 12 indexed citations

20.

Yang, Quanjun, Mingsong Fan, Bin Wu, et al.. (2011). Quality assessment for fructus Gardeniae by multi- component quantification, chromatographic fingerprint and related chemometric analysis. Journal of Medicinal Plants Research. 5(17). 4126–4137. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact